BIOMAT Database Logo BIOMAT Database Logo

Treatment of advanced colorectal cancer with mitoxantrone, high dose folinic acid and fluorouracil. 1991

G Comella, and R Casaretti, and P Comella, and A Daponte, and A Parziale, and V Iervolino, and G Santillo, and D Zarrilli
Divisione di Oncologia Medica A, Istituto Nazionale Tumori, Napoli, Italy.

A new combination chemotherapy including mitoxantrone 10 mg/m2 i.v. on day 1 and 5-fluorouracil 400 mg/m2 i.v. plus folinic acid 200 mg/m2 i.v. on days 1-5 was administered every 28 days to 13 patients with locally advanced or metastatic colon (1 case), ractosigmoid colon (4 cases), or rectum (8 cases) carcinoma. The median number of cycles performed was 3 (range, 1-9). No patient achieved complete or partial remission with this regimen, whereas 5 showed a stable disease lasting 3-8 months. Acute toxicity was mild/moderate in intensity and comparable to that reported with the standard 5-fluorouracil + folinic acid combination. Since we observed no major responses in our 13 consecutive patients, we consider that the overall activity of our regimen, at the doses and schedule utilized, was only moderately effective in advanced colorectal carcinoma.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008942 Mitoxantrone An anthracenedione-derived antineoplastic agent. Mitozantrone,CL-232325,DHAQ,Mitoxantrone Acetate,Mitoxantrone Hydrochloride,Mitroxone,NSC-279836,NSC-287836,NSC-299195,NSC-301739,NSC-301739D,Novantron,Novantrone,Onkotrone,Pralifan,Ralenova,Acetate, Mitoxantrone,CL 232325,CL232325,Hydrochloride, Mitoxantrone,NSC 279836,NSC 287836,NSC 299195,NSC 301739,NSC 301739D,NSC279836,NSC287836,NSC299195,NSC301739,NSC301739D
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D002955 Leucovorin The active metabolite of FOLIC ACID. Leucovorin is used principally as an antidote to FOLIC ACID ANTAGONISTS. Calcium Leucovorin,Citrovorum Factor,Folinic Acid,N(5)-Formyltetrahydrofolate,5-Formyltetrahydrofolate,5-Formyltetrahydropteroylglutamate,Calcium Folinate,Folinic Acid-SF,Leucovorin, (D)-Isomer,Leucovorin, (DL)-Isomer,Leucovorin, (R)-Isomer,Leucovorin, Calcium (1:1) Salt,Leucovorin, Calcium (1:1) Salt, (DL)-Isomer,Leucovorin, Calcium (1:1) Salt, Pentahydrate,Leucovorin, Monosodium Salt,Leukovorin,Leukovorum,Wellcovorin,5 Formyltetrahydrofolate,5 Formyltetrahydropteroylglutamate,Acid, Folinic,Factor, Citrovorum,Folinate, Calcium,Folinic Acid SF,Leucovorin, Calcium,Monosodium Salt Leucovorin
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

G Comella, and R Casaretti, and P Comella, and A Daponte, and A Parziale, and V Iervolino, and G Santillo, and D Zarrilli
High-dose folinic acid and 5-fluorouracil in advanced colorectal cancer.
January 1988, Cancer investigation,
G Comella, and R Casaretti, and P Comella, and A Daponte, and A Parziale, and V Iervolino, and G Santillo, and D Zarrilli
[Fluorouracil and high-dose folinic acid in the treatment of advanced colorectal carcinoma].
July 1990, La Clinica terapeutica,
G Comella, and R Casaretti, and P Comella, and A Daponte, and A Parziale, and V Iervolino, and G Santillo, and D Zarrilli
Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid.
January 1987, NCI monographs : a publication of the National Cancer Institute,
G Comella, and R Casaretti, and P Comella, and A Daponte, and A Parziale, and V Iervolino, and G Santillo, and D Zarrilli
Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid.
May 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
G Comella, and R Casaretti, and P Comella, and A Daponte, and A Parziale, and V Iervolino, and G Santillo, and D Zarrilli
Treatment of advanced colorectal cancer with high-dose intensity folinic acid and 5-fluorouracil plus supportive care.
November 1995, European journal of cancer (Oxford, England : 1990),
G Comella, and R Casaretti, and P Comella, and A Daponte, and A Parziale, and V Iervolino, and G Santillo, and D Zarrilli
Second-line treatment with high-dose 5-fluorouracil and folinic acid in advanced colorectal cancer refractory to standard-dose 5-fluorouracil treatment.
January 1995, Oncology,
G Comella, and R Casaretti, and P Comella, and A Daponte, and A Parziale, and V Iervolino, and G Santillo, and D Zarrilli
High-dose folinic acid and 5-fluorouracil bolus and continuous infusion in advanced colorectal cancer.
September 1988, European journal of cancer & clinical oncology,
G Comella, and R Casaretti, and P Comella, and A Daponte, and A Parziale, and V Iervolino, and G Santillo, and D Zarrilli
Treatment of advanced breast cancer with 5-fluorouracil and high-dose folinic acid: preliminary results.
April 1985, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy,
G Comella, and R Casaretti, and P Comella, and A Daponte, and A Parziale, and V Iervolino, and G Santillo, and D Zarrilli
High dose folinic acid and 5-fluorouracil bolus and continuous infusion for patients with advanced colorectal cancer.
October 1995, Cancer,
G Comella, and R Casaretti, and P Comella, and A Daponte, and A Parziale, and V Iervolino, and G Santillo, and D Zarrilli
High-dose folinic acid and 5-fluorouracil in the treatment of advanced colon cancer.
October 1988, American journal of clinical oncology,
Copied contents to your clipboard!